EUR 25.05
(0.2%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 23.86 Million EUR | 158.05% |
2022 | -41.11 Million EUR | -225.98% |
2021 | 32.63 Million EUR | 78.93% |
2020 | 18.24 Million EUR | -51.14% |
2019 | 37.32 Million EUR | -20.27% |
2018 | 46.81 Million EUR | 1.3% |
2017 | 46.21 Million EUR | 59.76% |
2016 | 28.93 Million EUR | -27.54% |
2015 | 39.92 Million EUR | 52.8% |
2014 | 26.12 Million EUR | 27.52% |
2013 | 20.48 Million EUR | 0.44% |
2012 | 20.39 Million EUR | 41.39% |
2011 | 14.42 Million EUR | 145.36% |
2010 | 5.88 Million EUR | -71.31% |
2009 | 20.49 Million EUR | -15.97% |
2008 | 24.38 Million EUR | 2.64% |
2007 | 23.76 Million EUR | 25.55% |
2006 | 18.92 Million EUR | -17.76% |
2005 | 23.01 Million EUR | 33.78% |
2004 | 17.2 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 10.98 Million EUR | 0.0% |
2023 FY | 23.86 Million EUR | 158.05% |
2023 Q2 | 2.08 Million EUR | 0.0% |
2023 Q4 | 21.78 Million EUR | 0.0% |
2022 FY | -41.11 Million EUR | -225.98% |
2022 Q4 | -44.44 Million EUR | 0.0% |
2022 Q2 | 3.33 Million EUR | 0.0% |
2021 Q4 | 9.25 Million EUR | 0.0% |
2021 Q2 | 23.38 Million EUR | 0.0% |
2021 FY | 32.63 Million EUR | 78.93% |
2020 Q4 | 9.51 Million EUR | 0.0% |
2020 Q2 | 8.19 Million EUR | 0.0% |
2020 FY | 18.24 Million EUR | -51.14% |
2019 Q4 | 18.29 Million EUR | 0.0% |
2019 Q2 | 19.03 Million EUR | 0.0% |
2019 FY | 37.32 Million EUR | -20.27% |
2018 Q4 | 24.4 Million EUR | 0.0% |
2018 Q2 | 22.41 Million EUR | 0.0% |
2018 FY | 46.81 Million EUR | 1.3% |
2017 FY | 46.21 Million EUR | 59.76% |
2017 Q2 | 23.08 Million EUR | 0.0% |
2017 Q4 | 23.13 Million EUR | 0.0% |
2016 FY | 28.93 Million EUR | -27.54% |
2016 Q2 | 12.12 Million EUR | 0.0% |
2016 Q4 | 16.8 Million EUR | 0.0% |
2015 Q4 | 18.74 Million EUR | 0.0% |
2015 Q2 | 20.49 Million EUR | 0.0% |
2015 FY | 39.92 Million EUR | 52.8% |
2014 FY | 26.12 Million EUR | 27.52% |
2014 Q4 | 14.07 Million EUR | 0.0% |
2014 Q2 | 12.05 Million EUR | 0.0% |
2013 Q2 | 10.01 Million EUR | 0.0% |
2013 Q4 | 10.47 Million EUR | 0.0% |
2013 FY | 20.48 Million EUR | 0.44% |
2012 Q1 | 5.09 Million EUR | 0.0% |
2012 FY | 20.39 Million EUR | 41.39% |
2012 Q4 | 5.12 Million EUR | 0.44% |
2012 Q3 | 5.09 Million EUR | 0.0% |
2012 Q2 | 5.09 Million EUR | 0.0% |
2011 FY | 14.42 Million EUR | 145.36% |
2011 Q3 | 3.6 Million EUR | 0.0% |
2011 Q1 | 3.6 Million EUR | 0.0% |
2011 Q2 | 3.6 Million EUR | 0.0% |
2011 Q4 | 5.09 Million EUR | 41.39% |
2010 Q1 | 1.47 Million EUR | 0.0% |
2010 Q3 | 1.47 Million EUR | 0.0% |
2010 FY | 5.88 Million EUR | -71.31% |
2010 Q4 | 3.6 Million EUR | 145.36% |
2010 Q2 | 1.47 Million EUR | 0.0% |
2009 Q3 | 5.12 Million EUR | 0.0% |
2009 Q1 | 5.12 Million EUR | 0.0% |
2009 FY | 20.49 Million EUR | -15.97% |
2009 Q4 | 1.47 Million EUR | -71.31% |
2009 Q2 | 5.12 Million EUR | 0.0% |
2008 Q3 | 6.09 Million EUR | 0.0% |
2008 Q2 | 6.09 Million EUR | 0.0% |
2008 Q1 | 6.09 Million EUR | 0.0% |
2008 FY | 24.38 Million EUR | 2.64% |
2008 Q4 | 5.12 Million EUR | -15.97% |
2007 Q4 | 6.09 Million EUR | 2.64% |
2007 Q3 | 5.94 Million EUR | 0.0% |
2007 Q2 | 5.94 Million EUR | 0.0% |
2007 Q1 | 5.94 Million EUR | 0.0% |
2007 FY | 23.76 Million EUR | 25.55% |
2006 Q1 | 4.73 Million EUR | 0.0% |
2006 FY | 18.92 Million EUR | -17.76% |
2006 Q3 | 4.73 Million EUR | 0.0% |
2006 Q2 | 4.73 Million EUR | 0.0% |
2006 Q4 | 5.94 Million EUR | 25.55% |
2005 Q1 | 5.75 Million EUR | 0.0% |
2005 Q4 | 4.73 Million EUR | -17.76% |
2005 Q3 | 5.75 Million EUR | 0.0% |
2005 Q2 | 5.75 Million EUR | 0.0% |
2005 FY | 23.01 Million EUR | 33.78% |
2004 FY | 17.2 Million EUR | 0.0% |
2004 Q2 | 4.3 Million EUR | 0.0% |
2004 Q1 | 4.3 Million EUR | 0.0% |
2004 Q3 | 4.3 Million EUR | 0.0% |
2004 Q4 | 5.75 Million EUR | 33.78% |
2003 Q4 | 4.3 Million EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Affluent Medical SA | -15.65 Million EUR | 252.469% |
Bluelinea Société Anonyme | -1.62 Million EUR | 1573.21% |
Carmat SA | -53.86 Million EUR | 144.304% |
Diagnostic Medical Systems S.A. | -4.94 Million EUR | 582.531% |
Euromedis Groupe | 13.11 Million EUR | -82.04% |
Eurobio Scientific Société anonyme | 4.83 Million EUR | -393.609% |
Ikonisys S.A. | -2.26 Million EUR | 1152.457% |
Implanet S.A. | -6.67 Million EUR | 457.49% |
Median Technologies SA | -22.98 Million EUR | 203.846% |
SpineGuard SA | -4.18 Million EUR | 670.491% |
Theraclion SA | -3.67 Million EUR | 749.414% |
Euroapi S.A. | -189.7 Million EUR | 112.581% |
Ion Beam Applications SA | -9.11 Million EUR | 361.976% |
Koninklijke Philips N.V. | -466 Million EUR | 105.121% |
Sequana Medical NV | -32.56 Million EUR | 173.29% |